Clinical Trial Update: Bevacizumab and Long Acting Gas in Diabetic Vitrectomy [Phase 3]

View source ↗

Summary

This clinical trial update reports completion of a Phase 3 study evaluating bevacizumab with long-acting gas in diabetic vitrectomy for proliferative diabetic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)
• C3F8 (Perfluoropropane) (perfluoropropane)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Proliferative Diabetic Retinopathy | Phase 3 | Status: COMPLETED